HOME >> BIOLOGY >> NEWS
Prestigious new nutrition research center being established at UNC-CH with NIH funding

CHAPEL HILL - To help reduce the staggering toll of unnecessary illness and premature death associated with chronic disease and to understand better the links between such diseases and nutrition, the National Institutes of Health has selected the University of North Carolina at Chapel Hill as home of the nation's newest Clinical Nutrition Research Unit.

"Over the next five years, we will receive $4.7 million from NIH to establish and operate this unit," said Steven Zeisel MD, Ph.D., chair of nutrition at the UNC-CH schools of public health and medicine and director of the new center.

"Our central goals will be to enhance the speed at which new laboratory discoveries are used in population-based and clinical research, to make sure that the education of health professionals includes nutrition and to help people learn how they can improve their diets to stay healthy."

UNC-CH will be one of only seven such units in the United States. Others are at Harvard, Washington University in St. Louis and the universities of Chicago, Washington at Seattle, Southern Alabama and Colorado at Denver.

"Although the United States is thought to have one of the best health care systems in the world, in terms of both dollars and in human costs we are overburdened with the expense of chronic diseases," Zeisel said. "About 90 million Americans suffer with a chronic disease. As people age, the patterns of nutritional intake play a significant role in the onset and progression of these diseases: five of the 10 leading causes of death have a strong relationship to poor diet."

Total estimated costs for chronic diseases in 1990 in this country were $659 billion with $435 billion in direct costs and $234 billion in indirect costs, he said. Obesity, for example, contributes significantly to many other chronic diseases such as diabetes mellitus, heart disease and certain cancers and has been estimated to result in $45.8 billion
'"/>

Contact: David Williamson
David_Williamson@unc.edu
919-962-8596
University of North Carolina at Chapel Hill
17-Oct-1999


Page: 1 2 3

Related biology news :

1. Rockefeller University Scientists Receive Prestigious Awards For Cancer Research
2. Scientist Receives Prestigious Award
3. Hultgren Receives Prestigious Eli Lilly Award
4. Improved nutrition could reduce malaria burden worldwide
5. International symposium on nutritional genomics
6. Improved nutrition could prevent more than half of the worlds child deaths annually
7. Understanding nutrition labels can lead to healthier eating
8. Highlights of Tufts University nutrition research: January 2004
9. One-size-fits-all approach to nutrition recommendations may soon be outdated
10. Enhancing the nutritional value of soybeans
11. Enhanced nutrition could result from rice research leading to high-protein flour

Post Your Comments:
(Date:8/25/2015)... LAKE CITY and BELLEVUE, Wash. ... global leader in advanced robotic systems, announced today it ... robotic unmanned ground vehicle (UGV), at the National Tactical ... City.  The Guardian S is the ... the culmination of years of research and in-field trials ...
(Date:8/20/2015)... CT ., Aug. 20, 2015 NXT-ID, ... a biometric authentication company focused on the growing mobile ... announces it has joined The Smart Card Alliance and ... Smart Card Alliance and the Smart Card Alliance Latin ... visibility to industry peers and thought leaders promoting adoption ...
(Date:8/12/2015)... 12, 2015   MedNet Solutions , an innovative ... of clinical research, is proud to announce that ... SaaS-based eClinical technology platform, has led the way to ... quarters of 2015.   Q2 2015 and Q1 2015 ... by contract value sold in the company,s 15 year ...
Breaking Biology News(10 mins):Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 2NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 4MedNet Solutions Experiences Explosive Corporate Growth 2
(Date:8/28/2015)... - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: ... the development of autologous cell therapies, today reported ... 2015, corporate highlights, and near-term milestones.  The company,s ... www.sedar.com ,  www.edgar.com and at ... to launch its RCS-01 treatment for aging and ...
(Date:8/27/2015)... ... August 27, 2015 , ... The Kansas ... investment firms and animal health companies to hear from animal health companies with ... have also received licensing agreements or distribution contracts. This meeting is one ...
(Date:8/27/2015)... /PRNewswire/ - Portage Biotech Inc. ("Portage") (OTC Market: ... Holding Company Limited (Biohaven), announced today that dosing ... BHV-0223, a glutamate modulating agent. Biohaven filed an ... obtained clearance from the U.S. Food and Drug ... holds 54% equity interest in Biohaven, a private ...
(Date:8/27/2015)... , Aug. 27, 2015 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ... and six-month periods ended June 30, 2015. Biorem,s complete second quarter ... ). FINANCIAL HIGHLIGHTS: in ,000,s except earnings per shareThree-months ended ... 2014 , 2015 , 2014 Revenue ... , 4,433 Gross profit , 1,656 , ...
Breaking Biology Technology:RepliCel Reports Second Quarter 2015 Financial Results 2RepliCel Reports Second Quarter 2015 Financial Results 3RepliCel Reports Second Quarter 2015 Financial Results 4RepliCel Reports Second Quarter 2015 Financial Results 5VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 2VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 2Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 4BIOREM Reports $718,000 Net Earnings for the Second Quarter 2BIOREM Reports $718,000 Net Earnings for the Second Quarter 3
Cached News: